The Cancer Immunology and Immunotherapy Centre (CIIC) is a collaborative grouping of academic and clinical research groups based at the University of Birmingham and the Queen Elizabeth Hospital Birmingham. They are collectively focused on developing internationally outstanding basic tumour immunology research and translating key discoveries into improvements in cancer treatment.
Also in 'Cancer Immunology and Immunotherapy Centre'
Cancer immunology research at the University of Birmingham
The future of cancer treatment
Professor Ben Willcox from the University of Birmingham's Institute of Immunology and Immunotherapy writes for the British Society of Immunology on the UK-wide Tumour Immunology Group.
Researchers in the University of Birmingham's Institute of Immunology and Immunotherapy have discovered a new target recognised by local T-cells involved in immunosurveillance in the gut.
Dr Leila Khoja joins Birmingham from AstraZeneca and Addenbrooke's Hospital, bringing with her an extensive experience in translating immunotherapies from bench to bedside.
View all news